← All Hyperfine, INC filings

Hyperfine, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
HYPR
Hyperfine, INC
10-K: Hyperfine's Portable MRI Advances Amidst Continued Losses
Hyperfine, Inc. reports continued net losses and negative cash flow for FY 2025 despite significant product innovation and strategic commercial expansion for its AI-powered portable MRI system.
NASDAQ
HYPR
Hyperfine, INC
10-K: Hyperfine Reports Increased Device Sales in 2024, Focuses on Market Expansion and Cost Streamlining
Hyperfine, Inc. reports a 17% increase in total revenues for 2024, driven by higher device sales and service revenue, while implementing cost-saving measures through organizational restructuring.
NASDAQ
HYPR
Hyperfine, INC
10-K: Hyperfine, Inc. Details Capital Stock Structure and Regulatory Landscape in 10-K Filing
Hyperfine, Inc.'s 10-K filing outlines the details of its capital stock, including Class A and Class B common stock, preferred stock, and various rights and restrictions, as well as the regulatory environment it operates within.